Entera Bio

Entera Bio Gross Profit

The Gross Profit of Entera Bio (ENTX) as of Nov 22, 2026 is -30,000.00 USD. In the previous year, Gross Profit was 9,000.00 USD — a change of -433.33% (lower).

Gross Profit

-30,000.00USD

YoY

-433.33%

Last updated:

Gross Profit of Entera Bio is 2025 -30,000.00 USD. Gross Profit of Entera Bio was 2024 9,000.00 USD. It decreases by -433.33% lower compared to the previous year.

The Entera Bio Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
500,000.00 USD
Jan 1, 2019
-212,000.00 USD
Jan 1, 2020
156,000.00 USD
Jan 1, 2021
198,000.00 USD
Jan 1, 2022
33,000.00 USD
Jan 1, 2023
-56,000.00 USD
Jan 1, 2024
9,000.00 USD
Jan 1, 2025
-30,000.00 USD
The Entera Bio Gross Profit history
YEARGross ProfitYoY
-30,000.00USD-433.33%
9,000.00USD-116.07%
-56,000.00USD-269.70%
33,000.00USD-83.33%
198,000.00USD+26.92%
156,000.00USD-173.58%
-212,000.00USD-142.40%
500,000.00USD-1,262.79%
-43,000.00USD+22.86%
-35,000.00USD+25.00%
-28,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Entera Bio Revenue

Entera Bio Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
365,000.00 USD
-11.13 M USD
-9.98 M USD
Jan 1, 2021
571,000.00 USD
-12.22 M USD
-12.19 M USD
Jan 1, 2022
134,000.00 USD
-13.02 M USD
-13.07 M USD
Jan 1, 2023
14,000.00 USD
-8.94 M USD
-8.89 M USD
Jan 1, 2024
181,000.00 USD
-9.59 M USD
-9.54 M USD
Jan 1, 2025
42,000.00 USD
-11.53 M USD
-11.44 M USD
Jan 1, 2026 (e)
0.00 USD
-34.68 M USD
-12.42 M USD
Jan 1, 2027 (e)
0.00 USD
0.00 USD
-16.19 M USD

Entera Bio Margins

Entera Bio stock margins

The Entera Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Entera Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Entera Bio.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
42.74 %
-3,050.14 %
-2,735.07 %
Jan 1, 2021
34.68 %
-2,139.58 %
-2,134.33 %
Jan 1, 2022
24.63 %
-9,714.18 %
-9,754.48 %
Jan 1, 2023
-400.00 %
-63,857.14 %
-63,492.85 %
Jan 1, 2024
4.97 %
-5,295.58 %
-5,271.27 %
Jan 1, 2025
-71.43 %
-27,450.00 %
-27,235.72 %
Jan 1, 2026 (e)
-71.43 %
- %
- %
Jan 1, 2027 (e)
-71.43 %
0.00 %
- %

Entera Bio Stock analysis

What does Entera Bio do? Entera Bio Ltd is an emerging biotechnology company focused on developing oral medications to treat unmet medical needs. The company was founded in 2010 and is headquartered in Jerusalem, Israel. Its history began with the discovery of the "EnteraGam" molecule in the intestinal cells of breastfed infants, which helps them fight infections. This led to the development of EnteraGam for the treatment of various autoimmune diseases. The company's business model is based on developing oral formulations for existing drugs and discovering and developing new molecules. Its focus areas are osteoporosis, hypoparathyroidism, chronic kidney disease, and autoimmune diseases. Entera Bio is divided into three business divisions: the Oral Protein Delivery Platform, the Oral Parathyroid Hormone (PTH) Platform, and the Collagen-based Platform for Wound Healing. Its products include EB611, a candidate for hypoparathyroidism treatment, EB613 for osteoporosis treatment, and EB612 for chronic kidney disease. These products have potential to improve the lives of millions of patients worldwide. Entera Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entera Bio stock

Gross Profit of Entera Bio is -30,000.00 USD in 2025.

Gross Profit of Entera Bio changed from 9,000.00 USD to -30,000.00 USD, representing a -433.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Entera Bio since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Entera Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Entera Bio

All Key Metrics — Entera Bio